Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Stock Split, History Data
Working capital analysis
In terms of working capital, Shin Nippon Biomedical Laboratories, Ltd. maintains a healthy position.
The total current assets of the company are valued at $23899564000.
This represents a growth rate of 48.127% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $10533094000, exhibiting a growth rate of 58.897% year-on-year.
The receivables, another significant portion of the current assets, are valued at $4760363000.
The year-on-year growth rate for receivables is 35.950%.
The inventory, which forms a critical part of the assets, is valued at $7329408000.
This represents a healthy year-on-year growth of 68.128%
On the liabilities side, the company's current liabilities total $21011689000.
This reflects a growth rate of 57.109% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
10533.09
6628.90
7230.74
5249.81
5141.52
5312.71
Receavebles
4760.36
3501.56
2954.09
2604.69
1986.81
2708.35
Inventory
7329.41
4359.42
4071.37
4031.73
3600.00
6439.47
Other
1276.70
1276.51
468.06
523.67
938.11
829.56
Total Current Assets
23899.56
16134.49
14780.03
12409.90
11666.43
15290.09
Acc Payable
419.76
64.57
95.01
119.26
36.57
84.63
Short Term Debt
8923.21
2942.74
3486.83
5998.28
11348.19
11523.88
Other Current Liab
3009.84
2685.14
2317.39
2033.15
2092.69
2307.15
Current Liabilities
21011.69
13373.97
11915.80
12951.16
17767.58
20002.90
Capital Structure
When examining the capital structure of Shin Nippon Biomedical Laboratories, Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Shin Nippon Biomedical Laboratories, Ltd. has chosen to reinvest in the business rather than distribute as dividends.
